Mr. David S. Seltzer is Chairman of the Board, President, Chief Executive Officer, Secretary, Treasurer of HiTech Pharmacal Co Inc. He was Chairman of the Board since September 2004 and Chief Executive Officer and President of the Company since May 1, 1998 and a Director, Secretary and Treasurer since February 1992. From July 1992 to May 1, 1998 Mr. Seltzer was Executive Vice President Administration and since July 1992, Vice President ? Administration and Chief Operating Officer of the Company since March 1992. Mr. Seltzer received a B.A. in Economics from Queens College in 1984. Mr. Seltzer?s experience brings to the Board an understanding of financial investment, business development, strategic planning, sales and operational management in industry and provides practical guidance, insight and perspective with respect to operations and strategy.
Chairman, CEO and President Secretary and Treasurer
Age: 51 Chairman Since 2004
|Seltzer received a B.A. in Economics from Queens College in 1984.|
The company has return on total asset (ROA) of 9.86 % which means that it generated profit of $9.86 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 12.98 % meaning that it created $12.98 on every $100 dollars invested by stockholders.
The company currently holds 1.33 M in liabilities with Debt to Equity (D/E) ratio of 0.01 which may suggest the company is not taking enough advantage from borrowing. Hi Tech Pharmacal Co Inc has Current Ratio of 6.54 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummaryHiTech Pharmacal Co., Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription and overthecounter solutions in the United States. Hi Tech Pharmacal Co Inc [HITK] is traded on NASDAQ in USA. It is located in HiTech Pharmacal Co., Inc.Amityville, NY and employs 427 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| HITK Nasdaq
Hi Tech Pharmacal Co Inc
Hi Tech Pharmacal Co Inc has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Hi Tech price boundaries
Promote Hi Tech and David Seltzer